Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator Licenses SpeechDx Dataset to Eli Lilly and Company, Advancing Speech-Based Markers as a Critical Alzheimer’s Research Tool
Lilly's partnership signals growing industry recognition of AI-driven speech analysis as a path to predicting Alzheimer's disease riskNEW YORK, Oct....